Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-24 @ 10:19 PM
NCT ID:
NCT00948935
Eligibility Criteria:
Inclusion Criteria:
* histologically or cytologically confirmed local advanced unresectable/metastatic adenocarcinoma of biliary tract
* measurable disease
* available tumor tissue for investigational immunohistochemical evaluations
* ECOG PS 0-2
* No prior chemotherapy, biologic therapy or radiation therapy
* Age Eighteen and older
* Lab values per protocol
Exclusion Criteria:
* Life expectancy less than three months
* Concurrent use of chemotherapy not indicated in the study protocol or any other investigational agents and patients who have received investigational drugs less than four weeks prior to enrollment
* Prior therapy, which affects or targets the EGF pathway
* Treatment for other carcinomas within the last five years, except cured non-melanoma skin and treated in-situ cervical cancer
* Recovery from major surgery within three weeks of the start of study treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00948935
Study Brief:
Protocol Section:
NCT00948935